Combination therapies employing platelet aggregation drugs

摘要

The present invention provides pharmaceutical compositions comprising a platelet aggregation inhibitor and a compound selected from pyridoxal-5'-phosphate, a pyridoxal-5'-phosphate related compound, or a pharmaceutically acceptable salt thereof. The invention also includes methods for using a platelet aggregation inhibitor and a compound selected from pyridoxal-5'-phosphate, a pyridoxal-5'-phosphate related compound, or a pharmaceutically acceptable salt thereof.